Bioforum’s Clinical Data Management team is fully committed to providing high-quality and reliable services using the industry’s leading technology designed for quality data capture.

The ISPOR Education Center provides instant access to Health Economics and Outcomes Research (HEOR) education with on-demand programs delivered through a personalized, powerful, and flexible learning platform. Working at their own time and pace, individuals can drive their professional development by growing their knowledge and skills with topical, relevant, and innovative course curricula.

Bioforum’s clinical research experts have developed an intuitive and easy-to-navigate analytics and visualization platform.
BioGRID brings clinical trial data together in a clear, focused manner to drive smart decision-making processes.

At inSeption Group, we don’t just crunch numbers—we transform data into confident action. Your trial’s success hinges on how well data is planned, analyzed, and delivered, and we make sure every finding moves your program forward.

Discover how a team of biostatistics and pharmacokinetics experts can offer specialized guidance for clinical trial design and analysis.

Our industry-leading clinical analytics experts build tools and solutions that efficiently facilitate data management and biometrics activities. By providing advanced services and automating technology, we're able to maximize efficiency, ease interpretation, and deliver actionable insights.

Compliance, Collaboration, Control: Streamlining the Development Process.

Navigating drug safety in the era of innovation-driven medicine

The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.